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Introduction 
Hospital Acquired Infections (HAIs) are considered to be one of the most serious patient 
safety issues in healthcare today. It has been shown that HAIs contribute significantly not 
only to morbidity and mortality, but also to excessive costs for the health care system and for 
hospitalized patients. Since possibilities of prevention and control exist, hospital quality can 
be improved while simultaneously the cost of care is reduced. The objectives of this study 
were to examine the prevalence and the excess costs associated with HAIs. 
 
Methods 
A retrospective observational study was performed to estimate costs associated with hospital–
acquired infections in Belgian hospitals, both in procedural admissions and in medical 
admissions. Hospital, diagnosis-related group, age and gender were used as matching factors 
to compare stays associated with HAIs and without HAIs. Data were obtained from the 
Minimum Basic Data Set 2008 used by Belgian hospitals to register case-mix data for each 
admission to obtain reimbursement from the authorities. Data included information from 45 
hospitals representing 16,141 beds and 2,467,698 patient stays. Using the 2008 national 
feedback programme of the Belgian government, cost data were collected (prolonged length 
of stay, additional pharmaceuticals and procedures) and subsequently linked to the data set. 
By means of a sensitivity analysis we estimated potential monetary savings when a reduction 
in the incidence of HAIs in hospitals having a higher rate of hospital-acquired infections in 
comparison to other hospitals would be realized.  
 
Results 
In our sample 5.9% of the hospital stays were associated with a hospital-acquired infection. 
The additional mean cost of the hospital-acquired infection was € 2,576 for all stays and € 
3,776 for procedural stays (P<0.001). The burden of disease in Belgium is estimated at € 
533,076,110 (all admissions) and € 235,667,880 (procedural admissions). The excess length 
of stay varied between hospitals from 2.52 up to 8.06 days (Md= 4.58, SD= 1.01), 
representing an associated cost of € 355,060,174. The cost of additional medical procedures 
and additional pharmaceutical products was estimated at € 62,864,544 and € 115,151,939. We 
provide a full overview of the potential monetary savings when reductions in HAIs are 
realized by applying different thresholds. For instance, if all Belgian hospitals having a higher 
rate of hospital-acquired infections improve their rate to the level of the hospital 
corresponding to percentile 75 (= 7.5% HAI) savings would be € 17,799,326.  
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Discussion 
Since opportunities in prevention and control exist, HAIs are an important possibility to 
improve hospital quality while simultaneously the cost of care delivery is reduced. In this 
report, we estimated the burden of hospital-acquired infections from a public healthcare 
provider’s perspective. Many western countries are seeking ways to improve cost-
effectiveness of hospital care delivery by increasing provider accountability. While this is a 
valuable avenue for policy improvement, not all HAIs are preventable and therefore shifting 
all risk to providers seems not desirable. Furthermore, excess costs estimated for HAIs should 
definitely not be interpreted as financial resources which would become available in the short 
term. Cost savings realised could be used to install supportive policy measures to increase the 
knowledge and practice of HAI prevention, thereby improving quality and safety of hospital 
care delivery. 
 
 
